NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I go back to the importance of processing dcvax-l through the system first. I'm getting bad reception on my phone, but in a nutshell, there is an order to things. Direct's turn is coming. The European Union also has the 4b rule. 4b is critical to post phase 3 success because it will take 1 year to get ema and fda approval. That year patients will be saved by 4b. The price must be established in Germany, and it will be used as a keystone for other national pricing. It's too much to type on this little phone, but there are reasons to place the direct party on ice until dcvax-l gets a price point. The DMc decision is coming. I believe the pseudo progression group is the reason it's taking longer. It's a nonprimary endpoint, it's the equivant of a separate but equal trial, with separate analysis and ultimately complimentary. There is much more detail to what I am saying, but I think the agencies and nwbo are all trying to make this happen soon and without error. I think this is a very exciting time in the advancement of science, international medical cooperation, and we will look back at this with great admiration toward patients, governments, nwbo, scientists, doctors, caregivers and even investors. Nwbo listed some of the firsts they've accomplished thus far....that list will grow. Imho